Gastrointestinal Endoscopic Device Market to More than Double in Value by 2016 in the U.S.
Anti-Reflux Device Market Grows over 300% in 2009
Gastrointestinal endoscopy is a non-invasive procedure used to diagnose and treat malfunctions and diseases in the digestive track. The largest segment of this market was GI endoscopes, which represented 32% of the overall market in 2009. However, capsule endoscopic devices will experience significant growth to become the second-largest market segment by 2016, due to advancements in camera capsule technology. In addition, the ultrasound endoscope market is expected to grow at a CAGR of 16% as more physicians are trained to use the devices.
“Nearly 50% of all GI procedures performed in 2009 were colonoscopies, reflecting the growing frequency of regular colon exams for early diagnosis of colorectal cancer,” says Dr.
iData’s global series on the Markets for Gastrointestinal Endoscopic Devices 2010 includes comprehensive analyses of the markets for gastrointestinal endoscopes, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, ERCP devices, biopsy forceps, polypectomy snares and FNA devices, foreign-body retrieval devices, hemostasis devices, anti-reflux devices and enteral feeding devices. The report series also includes comprehensive competitive analyses, which cover companies such as Boston Scientific, ConMed, Cook Medical, EndoGastric Solutions, Given Imaging and Olympus, among many others.
For more information, register free on iData’s website at: http://www.idataresearch.net/idata/registration.php
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device, dental and pharmaceutical companies. iData covers research in: endoscopy, video and high-tech, orthopedics, cardiovascular, dental, pharmaceuticals and more.
SOURCE iData Research Inc.
